Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Crilley

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|March 1, 1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantationP Crilley, D Topolsky, M J Styler, et al.
American Journal of Clinical Oncology|June 1, 1990
An unusual extramedullary relapse of acute nonlymphocytic leukemia after allogeneic bone marrow transplantationB P Kelch, S I Bulova, P Crilley, et al.
Blood|September 1, 1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2J C Biggs, J Szer, P Crilley, et al.
American Journal of Clinical Oncology|March 10, 2001
Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?R A Ener, S B Meglathery, B Cuhaci, et al.
Seminars in Oncology|August 1, 1993
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an updateI Brodsky, J C Biggs, J Szer, et al.
Seminars in Oncology|August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.
Blood|August 1, 1991
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2E A Copelan, J C Biggs, J M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Seminars in Oncology|August 1, 1993
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2)E A Copelan, J C Biggs, J Szer, et al.
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|March 1, 1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantationP Crilley, D Topolsky, M J Styler, et al.
American Journal of Clinical Oncology|June 1, 1990
An unusual extramedullary relapse of acute nonlymphocytic leukemia after allogeneic bone marrow transplantationB P Kelch, S I Bulova, P Crilley, et al.
Blood|September 1, 1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2J C Biggs, J Szer, P Crilley, et al.
American Journal of Clinical Oncology|March 10, 2001
Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?R A Ener, S B Meglathery, B Cuhaci, et al.
Seminars in Oncology|August 1, 1993
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an updateI Brodsky, J C Biggs, J Szer, et al.
Seminars in Oncology|August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.
Blood|August 1, 1991
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2E A Copelan, J C Biggs, J M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Seminars in Oncology|August 1, 1993
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2)E A Copelan, J C Biggs, J Szer, et al.
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Pageof 4